by Lowey Admin | Jul 10, 2024 | Homepage, News
Lowey Dannenberg is pleased to announce that on July 8, 2024, seven days before trial was to commence in HCSC v. Indivior Inc., et al., CL20-1474 (lead case), Plaintiffs Aetna, Inc. Blue Cross Blue Shield of Massachusetts, Inc., Health Care Service Corp., Blue Cross...
by Lowey Admin | May 6, 2024 | Homepage, News, Securities
Lowey Dannenberg P.C. is proud to announce that the firm has been included in this year’s ISS Securities Class Action Services (“ISS SCAS”) Top Plaintiff Law Firms of 2023 report, as the Firm was ranked #1 Law Firm based on Antitrust Settlements. The Firm topped the...
by Lowey Admin | Dec 19, 2023 | Homepage, News
On December 7, 2023, Lowey Dannenberg, P.C. and its co-counsel, representing named Plaintiff CareFirst BlueCross BlueShield,filed suit against Stelara manufacturer Johnson & Johnson (“J&J”) in the U.S. District Court for the Eastern District of Virginia. The...
by Lowey Admin | Jun 6, 2023 | Homepage, News
On June 6, 2023, Chief Judge Thomas Schroeder of the Middle District of North Carolina appointed Lowey co-lead counsel along with Korein Tillery, Quinn Emanuel, and Cohen Milstein in the multidistrict litigation In re Crop Protection Product Loyalty Program Antitrust...
by Lowey Admin | Feb 6, 2023 | Homepage, News
On February 1, 2023, the Federal Trade Commission (“FTC”) filed a first-of-its-kind enforcement action against GoodRx alleging unfair and deceptive business practices and violations of the Health Breach Notification Rule (“HBDNR”).[1] The FTC alleged GoodRx shared...
